Solve M.E.’s 2026 State of the Union: From Protecting Progress to Building What’s Next
In our 2026 State of the ME/CFS Union Address, Solve M.E. leadership shared a vision for accelerating research, strengthening the infrastructure behind scientific progress, and building a more powerful advocacy […]
Sign up for “The Solve M.E. 2026 Community Address: Shaping What Comes Next”
On October 20th at 1 pm PT / 4 pm ET, Solve M.E. is bringing our community together for the 2026 Community Address: Shaping What Comes Next, a live conversation about […]
Solve M.E. Statement on Proposed Political Review of NIH Grants
Solve M.E.released the following statement in response to news reports that the administration is drafting an executive order to establish an external committee to review the National Institutes of Health […]
Sequence ME & Long Covid: The Search for ME/CFS and Long Covid Biomarkers and Subtypes
The DecodeME Project is the largest genetic study of ME/CFS conducted to date and has identified eight genetic signals where people with ME/CFS tend to differ from those without, linked […]
Webinar Replay: GLP-1 Drugs to Reduce Symptoms in People with ME/CFS and Identify Disease Subgroups
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the natural GLP-1 hormone, which helps regulate insulin levels. Thus, these medicines help control blood sugar […]
